title: [Treatment research progress on the treatment of neurofibromatosis type 2-associated vestibular schwannoma].
abstract: Neurofibromatosis type 2 (NF2) is a dominantly inherited genetic condition. Bilateral vestibular schwannoma, which are benign tumors, composed of neoplastic Schwann cells that arise from the eighth cranial nerve, are the hallmark of NF2. Standard approaches for treatment of growing vestibular schwannoma include observation, surgical removal and radiation therapy. Molecular targeted therapies also present great prosperity in recent years. In this review, we summarize the latest progresses on the treatment of NF2-associated vestibular schwannoma.
authors.forename: Yingchao
authors.initials: Y
authors.lastname: Zhao
authors.forename: Qin
authors.initials: Q
authors.lastname: Yang
authors.forename: Yao
authors.initials: Y
authors.lastname: Jiang
mesh_terms: D006801:Humans; D058990:Molecular Targeted Therapy; D016518:Neurofibromatosis 2 / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D009464:Neuroma, Acoustic / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*